Journey Medical DERM
NASDAQ DERM
$6.61 -0.11 (-1.64%)
At close: Oct 2, 2026 · 4:00 PM EDT

Journey Medical (DERM) Capital Expenditures (2022 - 2023)

Updated

Journey Medical (DERM) recorded Capital Expenditures of $15 million in FY2024, up 200.0% from $5 million in FY2023.

Analysis

Journey Medical (DERM) Capital Expenditures (2022 - 2023) Analysis & Trends

  • Per Business Quant data, DERM's Capital Expenditures was $5 million in FY2023 (-75.0%) and $20 million in FY2022.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Capex (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 2.93 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 1.32 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 322.00 Mn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn 893.00 Mn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn -321.00 Mn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn -763.00 Mn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 513.00 Mn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn 140.00 Mn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 533.00 Mn
10 Journey Medical 181.73 Mn 79.82 Mn 12.37 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2023 5.00 Mn
Mar 31, 2022 20.00 Mn
API Access

Journey Medical Capital Expenditures API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=capital-expenditures&ticker=DERM&period=max&api_key=YOUR_API_KEY